Afghanistan vs Bangladesh: Average non-HDL cholesterol levels
Afghanistan
3.1
in 2018
Bangladesh
3.1
in 2018
Afghanistan rank
134th
Bangladesh rank
134th
Average non-HDL cholesterol levels over time
- Afghanistan
- Bangladesh
How they compare
Afghanistan currently reports 3.1 against 3.1 in Bangladesh, a difference of 0.
The two have swapped places 5 times across 39 shared years of data; in 1980 it was Afghanistan ahead.
Afghanistan ranks 134th and Bangladesh ranks 134th of 191 countries.
Afghanistan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Afghanistan | Bangladesh | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.98 | 2.93 | 0.05 | Afghanistan |
| 1990s | 3.1 | 3.06 | 0.04 | Afghanistan |
| 2000s | 3.1 | 3.1 | 0 | — |
| 2010s | 3.1 | 3.1 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Afghanistan or Bangladesh?
- Afghanistan, at 3.1 against 3.1 in Bangladesh as of 2018.
- What is the difference in average non-hdl cholesterol levels between Afghanistan and Bangladesh?
- 0, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Bangladesh?
- 39 years are reported by both, from 1980 to 2018.
- How do Afghanistan and Bangladesh rank globally for average non-hdl cholesterol levels?
- Afghanistan ranks 134th and Bangladesh ranks 134th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.